SCHEMBL4853716

SCHEMBL4853716

Cc1ccccc1-c1ccc(C=O)c(OCCN(C)C)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 4/20 0.48
ALDH1A1 P00352 4/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
KDM4E B2RXH2 2/20 0.46
SLC6A9 P48067 2/20 0.46
ADRB2 P07550 2/20 0.44
ADRB1 P08588 2/20 0.44
DRD2 P14416 1/20 0.43
DRD1 P21728 1/20 0.43
DRD4 P21917 1/20 0.43
DRD5 P21918 1/20 0.43
NMT2 O60551 1/20 0.43
NMT1 P30419 1/20 0.43
HPGD P15428 1/20 0.42
HTT P42858 1/20 0.42
HRH1 P35367 1/20 0.42
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4845580 0.91 SLC6A9 (0.49) HTR7ALDH1A1SMN1; SMN2KDM4ESLC6A9
SCHEMBL4852186 0.85 SLC6A9 (0.46) HTR7ALDH1A1KDM4ESLC6A9ADRB2
SCHEMBL4855017 0.84 KDM4E (0.49) HTR7ALDH1A1SMN1; SMN2KDM4ESLC6A9
SCHEMBL4851155 0.80 SLC6A9 (0.46) HTR7ALDH1A1SMN1; SMN2KDM4ESLC6A9
SCHEMBL4854461 0.79 DRD2 (0.46) ALDH1A1KDM4ESLC6A9DRD2DRD1
SCHEMBL5735316 0.78 ALDH1A1 (0.51) ALDH1A1KDM4ETSHR
SCHEMBL4888000 0.78 ALDH1A1 (0.69) HTR7ALDH1A1SMN1; SMN2KDM4EADRB2
SCHEMBL4854610 0.78 ALDH1A1 (0.49) HTR7ALDH1A1SMN1; SMN2KDM4ESLC6A9
SCHEMBL4853912 0.78 HTR7 (0.54) HTR7ALDH1A1SMN1; SMN2KDM4ESLC6A9
SCHEMBL4856307 0.78 HTR7 (0.48) HTR7ALDH1A1SMN1; SMN2KDM4ESLC6A9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed
EP-1515940-A2 AMINOALKOXY-FUNCTIONAL CHALCONES Lica Pharmaceuticals A/S (DK) 2005-03-23 EP disclosed
WO-2003097574-A2 AMINOALKOXY-FUNCTIONAL CHALCONES LICA PHARMACEUTICALS A/S (DK) 2003-11-27 WO disclosed